Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LYT-300 Safety, PK, and PD in Healthy Volunteers
NCT05129865Phase 2Completed
- Sponsor
- PureTech Health
- Start
- Dec 2021
- Primary completion
- Oct 2023
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GlyphAllo in anxiety disorder, postpartum depression (PPD), sponsored by PureTech Health. Started Dec 2021; status: completed.
02
Drugs
GlyphAllo
03
Conditions
anxiety disorderpostpartum depression (PPD)
Beyond the preview
Go deeper on NCT05129865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05129865.